Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Thrombosis Research|April 23, 2003
An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trialPatricia Massicotte, Jim A Julian, Michael Gent, et al.Thrombosis Research|December 25, 2003
A cross-sectional study evaluating post-thrombotic syndrome in childrenStefan Kuhle, Barbara Koloshuk, Velma Marzinotto, et al.Journal of the American College of Cardiology|December 19, 2012
Factors associated with thrombotic complications after the Fontan procedure: a secondary analysis of a multicenter, randomized trial of primary thromboprophylaxis for 2 years after the Fontan procedureBrian W McCrindle, Cedric Manlhiot, Andrew Cochrane, et al.Journal of the American College of Cardiology|July 30, 2011
A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in childrenPaul Monagle, Andrew Cochrane, Robin Roberts, et al.American Journal of Ophthalmology|April 5, 2002
Effective treatment of ligneous conjunctivitis with topical plasminogenPatrick Watts, Palanisamy Suresh, Eedy Mezer, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 13, 2003
Fibrinolytic response to venous occlusion is decreased in patients after Kawasaki diseaseManuela Albisetti, Anthony K C Chan, Brian W McCrindle, et al.Thrombosis Research|April 23, 2003
Dose-finding and pharmacokinetic profiles of prophylactic doses of a low molecular weight heparin (reviparin-sodium) in pediatric patientsPatricia Massicotte, Jim A Julian, Velma Marzinotto, et al.Thrombosis and Haemostasis|May 15, 2002
Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study. Prophylactic Antithrombin Replacement in Kids with ALL treated with AsparaginaseChristoph Male, Peter Chait, Jeffrey S Ginsberg, et al.Thrombosis and Haemostasis|July 31, 2003
Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA studyLesley Mitchell, Maureen Andrew, Kim Hanna, et al.Cancer|January 9, 2003
A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) StudyLesley G Mitchell, Maureen Andrew, Kim Hanna, et al.Pageof 2